Clinical Trial Update: A 28 Day Study of ONO-9054 Ophthalmic Solution in Subjects With Ocular Hypertension (OHT) or Open-angle Glaucoma (OAG) [Phase 2]

View source ↗

Summary

Phase 2, 28-day study of ONO-9054 ophthalmic solution in ocular hypertension and open-angle glaucoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ocular Hypertension
• Open-angle Glaucoma

Drugs mentioned

• ONO-9054 ophthalmic solution (ONO-9054)

Snippet

Sponsor: Ono Pharmaceutical Co., Ltd. | Conditions: Ocular Hypertension, Open Angle-glaucoma | Phase 2 | Status: COMPLETED